GMP refers to the Good Manufacturing Practice Regulations promulgated by the US Food and Drug Administration under the authority of the Federal Food, Drug, and Cosmetic Act (See Chapter IV for food, and Chapter V, Subchapters A, B, C, D, and E for drugs and devices.) These regulations, which have the force of law, require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood take proactive steps to ensure that their products are safe, pure, and effective.

GMP regulations require a quality approach to manufacturing, enabling companies to minimize or eliminate instances of contamination, mixups, and errors. This, in turn, protects the consumer from purchasing a product that is not effective or even dangerous. Failure of firms to comply with GMP regulations can result in very serious consequences including recall, seizure, fines, and jail time.

GMP regulations address issues including recordkeeping, personnel qualifications, sanitation, cleanliness, equipment verification, process validation, and complaint handling. Most GMP requirements are very general and open-ended, allowing each manufacturer to decide individually how to best implement the necessary controls. This provides much flexibility, but also requires that the manufacturer interpret the requirements in a manner that makes sense for each individual business.

Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.

GMP covers all aspects of production from the starting materials, premises, and equipment to the training and personal hygiene of staff. Detailed, written procedures are essential for each process that could affect the quality of the finished product. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process – every time a product is made.

Of course, I am extremely proud that the company I represent subscribes to this process / practice. Recently an array of CBD oil samples was tested in an independent lab, 67% of the samples did not contain what the labels said they did, and 2% did not contain ANY CBD at all!

Be sure to choose your CBD supplier VERY carefully

A recent exploratory scientific endeavor was conducted to research and assess the stability of CBD in 10xPURE hemp oil in comparison to standard hemp oil by examining the cells that metabolize the CBD molecules.

The exploratory scientific endeavor was completed by CTFO to assess how 10xPURE affects the absorption and stability of full-spectrum CBD in hemp oil. Using a technique called mass spectrometry, routinely used to accurately detect small molecules such as cannabinoids, measurements were taken to detect the presence of CBDA in the liver cells. Under the same conditions, CBDA was not detected with the standard hemp oil, yet was present in the cells with the 10xPURE hemp oil.

Liquid chromatography separates molecules based on their chemical properties and is routinely used in most cannabis testing labs to quality control their material. Using this method, the composition of the 10xPURE hemp oil and the standard hemp oil were tested. With the same amount of full-spectrum CBD, we observed that the 10xPURE hemp oil contained significantly more CBDA.

View the FULL REPORT